nr_heny2012.pptx
TRANSCRIPT
Intracellular Receptor A site of Drug Action
Heny Ekowati
Department of Pharmacy,
Faculty of Medicine and Health Sciences
UNSOED, 2011
Nuclear Receptors1. Proteins interact with steroids and other
hormones that diffuse through the cell membrane.
2. Form hormone-receptor complexes that function as activators by binding to enhancers hormone response elements.
3. Sex hormones: estrogens and androgens; glucocorticoids, cortisol, vitamin D Ca2+ metabolism; thyroid hormone, retinoic acid developmental factors.
Steroid Hormone Receptor Signaling
Steroid hormones are produced by endocrine glands
Essential regulators of: reproduction, secondary sex characteristics
Development, differentiation
Glucose metabolism
Response to stress and salt balance
Nuclear Receptor Superfamily
large family of structurally related ligand-inducible transcription factors, including: steroid receptors (SRs), thyroid/retinoids receptors (TR, RARs and RXRs),
vitamin D receptors (VDR), estrogen receptors (ERa and ERb), and orphan receptors for which no ligand has
been yet identified. While having in common a modular structure, they
are activated by distinct lipophilic small molecules such as glucocorticoids, progesterone, estrogens, retinoids, and fatty acid derivatives
All steroids are synthesized from cholesterol.
Characterized by the presence of 3 functional domains: DNA-binding domain (DBD): 2 Zn finger motifscentrally located
Ligand-binding domain (LBD): C-terminal, 12 a helicesLBD: 1. Ligand-dependent nuclear translocation signal
2. Chaperone protein binding 3. Dimerization interface
4. Ligand-depndent activation function domain (AF-2) Transactivation domain: ligand–independent AF-1
AF domains are a-helical structures that can recruit co-activators.
Steroid Hormone Receptors
Receptor activation induces the modulation of transcription of specific genes that has hormone receptor elements (HRE).
Responses to hydrophobic hormones are mediated by intracellular
receptors
Transcription
Translation
Cytoplasm
Nucleus
Nuclear envelope
Plasma membrane Lipophilic hormone carried
in blood
Hormone binds intracellular receptor inducing receptor dimerization and activation
Complex is imported into nucleus
Binds to “hormone response element” to regulate gene expression
Intracellular receptor
Promoter Target gene“Hormone response element”
Target cell
LipophillicHormone
Fig.15-12
Thyroid hormone receptors exist as dimers
Estrogen Reseptor
Estrone [53-16-7]
Estradiol-17b [50-28-2]
Estradiol-17a [57-91-0]
Primary estrogen produced by the ovaries.
Estriol [50-27-1]
Formed from estradiol, weak estrogen, predominant estrogen after menopause.
Weak estrogen, used to treat menopause symptoms.
Estrogens(oestrogen)
Estrogen Action Stimulates tissue growth by:
promoting cell proliferation (DNA synthesis and cell division) in female sex organs (breasts, uterus),
promoting hypertrophy, or increasing a cell's size, such as occurs in female breast and male muscle during puberty and
initiating synthesis of specific proteins. Gene transcription of: myc, cyclin D, TGFa, Bcl2,
Cathepsin D, NOS
Estrogen Receptors ER-a
Uterus, testis, pituitary, ovary, epididymis, and adrenal gland.
ER-b (Kuiper et al. 1996) brain, kidney, prostrate, ovary, lung, bladder, intestine,
and epididymis. 88% identity with rat ER-b;
47% identity with human ER-a
Both ERs are localized to membrane, cytosol, and nucleus.
ERa and b differ in C-terminal ligand binding domains and N-terminal transactivation domains. Highest homology in DNA binding domain.
Estrogen-related orphan receptors (ERR) , , a b g
Estrogen Receptors
http://www.bio.cmu.edu/Courses/BiochemMols/ER/#ERchime
Estrogen Receptor
DNA pol a
Cyclins E,A
B-Myb
I-Classical Mechanism: ERE dependent Gene Transactivation
Mechanism
Osborne, C. K.; Zhao, H.; Fuqua, S. A. Selective estrogen receptor modulators: structure, function, and clinical use. J Clin Oncol 2000, 18, 3172-3186.
20
Molecular Action of Estrogen
Adopted from Stanley J Birge et al
AP I – activator protein
CRP – co regulator protein
ER – estrogen receptor
ERE – estrogen response element
Poly II – polymerase II
TATA- adenine-thymine-rich sequence important for gene transcription
21SERMs - Prof.S.N.Panda - 45th. AICOG
Molecular Action of EstrogenDifferent response in different
tissues
Adopted from Lewis J. Kleinsmith Ph.D, Donna Kerrigan M.S., Jeanne Kelly
ER effects on different cell types
Copyright ©2005 The Endocrine Society
Bjornstrom, L. et al. Mol Endocrinol 2005;19:833-842
Fig. 2. Schematic Illustration of How Genomic and Nongenomic Actions of ERs on a Target Gene Promoter May Converge
24SERMs - Prof.S.N.Panda - 45th. AICOG
Effects of Estrogen at Various Sites in the Body
Tissue Effect of Estrogen Stimulation
Clinical Effect of Stimulation
Clinical Effect of Absence of Stimulation
Bone Increased deposits of calcium into bone
Increased bone density Osteoporosis
Brain Blocks the release of ovarian estrogen
NoneHot flashes, sleep disorders, mood changes, problems with memory? Alzheimer’s disease??
BreastStimulates growth of breast tissue
Bigger breasts,? Increased risk of breast cancer, increased sensitivity of the breast,
Smaller breasts
Blood Clotting
Increased risk of blood clots No change in clotting
Blood Fats Increased HDL, decreased LDL, decreased Cholesterol,
Decreased HDL, increased LDL, increased Cholesterol
Skin Increased fat deposits in skin Softer skin Thinner skin, liver spots, dry skin
Uterus Increased stimulation of uterine lining and muscle
Heavier cycles, increased risk of uterine cancer No periods
VaginaIncreased thickening of skin, better blood supply to tissue
Vaginal discharge, feelings of pelvic congestion
Dryness, vaginal infections, painful sex, incontinence of urine, pelvic weakness
ORMELOXIFENE
The individual elements of the molecular structure give a tissue selectivity- different
DNA transcriptions in different tissues
Estrogen agonist
Estrogen antagonist
Chemical Name- Trans -7-methyl-2-2-dimethyl-3-phenyl-4(4-(2-
pyroldinoethoxy)phenyl(-chroman hydrochloride), related to
centchroman
The perfect SERM
27
The perfect SERMORMELOXIFENE
Enhanced tissue selectivity Basic amine side chain – uterine AE
action Pyrolidine base – highest degree of
antagonistic action Benzopyran group – agonistic action &
binding affinity Very strong binding affinity to ER
Quick & potent action Slow nuclear build up & prolonged
retention of ER Long half life & prolonged action
28
An optimally designed potent SERM with Varied Tissue ResponseOestrogen Antagonist in UTERUS &
BREASTMild Oestrogenic action on Vagina, Bone mineral density, CNS and Serum LipidsNo action on Hypothalamic Pituitary Ovarian function, Thyroid, Adrenal.
The perfect SERM
ORMELOXIFENE
No Progestational, Androgenic or Antiandrogenic properties
29
ORMELOXIFENE
Special benefit in perimenopausal women – Relief of PMS
Currently indicated for the treatment of Dysfunctional Uterine Bleeding at ANY AGE.Not suitable for women desiring pregnancy
Approved for inclusion in National Family Welfare Program, for social marketing.
The perfect SERM
30
ORMELOXIFENE
Currently being evaluated for use in the treatment and prevention of: -• Breast Cancer• Osteoporosis Possible future use: -• Menopause management• Fibromyoma• Endometriosis and Adenomyosis• Contraceptive
The perfect SERM
Glucocorticoid
Receptor
Formation of a receptor/ligand complex can occur in the cytosol or the nucleus and typically leads to dimerization of the occupied receptor.Dimerized receptor binds to the hormone regulatory element (HRE, 8-15 base pairs) on the target DNA molecule changes in gene transcription
Positive and Negative Transcriptional Effects of Steroid Receptors
Binding of a receptor dimer imme-diately adjacent to a transcriptionfactor leads to synergistic activa-tion of transcription
Binding of a receptor dimer to anegative hormone response ele-ment may displace a positive transcription factor.
Protein-protein interaction between receptordimer and a positive transcription factor such as AP 1 may block AP 1/DNA bindingand repress the transcriptional response.Figure 22.15 – Devlin, Textbook of
Biochemistry
NF-B Proteins: Latent Gene Regulatory Proteins Pivotal to Most Inflammatory Responses
• Proinflammatory cytokines, suchas TNF-, bind to their specificmembrane receptors and initiatea pathway that activates NF-B,normally sequestered in aninactive state through associationwith IB proteins.
• Once activated, NF-B turns onthe transcription of > 60 genesthat participate in inflammatoryresponses.
• Degradation of IB exposes a nuclear localization signal on NF-B, which move into the nucleus.
• A TNF-/receptor interactioninitiates of pathway that marksIB for degradation.
A glucocorticoid interaction with its receptor results in increasing the transcriptionof the protein IB, which binds and inhibits the activity of NF-B, a a transcriptionalactivator that stimulates transcription of genes for inflammatory cytokines.
Glucocorticoid induction of IB synthesis through GCbinding to its intracellularreceptor and stimulating trans-cription of the gene.
IB binds toand inhibits thenuclear translo-cation of NF-B.
NF-B stimulates theultimate production ofinflammatory cytokinesTumor necrosis factor (TNF)
binding to its receptor leads tothe ultimate degradation of IB
How glucocorticoids suppress immune and inflammatory reactions mediated by cytokines
Thank you for your attention